tradingkey.logo

OptimizeRx Corp

OPRX

12.885USD

+0.385+3.08%
Horarios del mercado ETCotizaciones retrasadas 15 min
238.28MCap. mercado
PérdidaP/E TTM

OptimizeRx Corp

12.885

+0.385+3.08%
Más Datos de OptimizeRx Corp Compañía
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Información de la empresa
Símbolo de cotizaciónOPRX
Nombre de la empresaOptimizeRx Corp
Fecha de salida a bolsaMay 18, 2005
Director ejecutivoMr. Stephen L. (Steve) Silvestro
Número de empleados106
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 18
Dirección260 Charles Street
CiudadWALTHAM
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02453
Teléfono12486516558
Sitio Webhttps://www.optimizerx.com/
Símbolo de cotizaciónOPRX
Fecha de salida a bolsaMay 18, 2005
Director ejecutivoMr. Stephen L. (Steve) Silvestro
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
119.10K
+65.06%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
62.93K
+17.74%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
51.60K
-2.62%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
46.65K
-47.02%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
42.05K
+30.66%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Ms. Marion K. Odence-Ford
Ms. Marion K. Odence-Ford
General Legal Officer and Chief Human Resources Officer
General Legal Officer and Chief Human Resources Officer
--
--
Mr. Andy Dsilva
Mr. Andy Dsilva
Investor Relations
Investor Relations
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
119.10K
+65.06%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
62.93K
+17.74%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
51.60K
-2.62%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
46.65K
-47.02%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Whetstone Capital Advisors, LLC
8.16%
Weintraub (Michael)
7.49%
BlackRock Institutional Trust Company, N.A.
6.31%
The Vanguard Group, Inc.
4.98%
Royce Investment Partners
4.27%
Other
68.79%
Accionistas
Accionistas
Proporción
Whetstone Capital Advisors, LLC
8.16%
Weintraub (Michael)
7.49%
BlackRock Institutional Trust Company, N.A.
6.31%
The Vanguard Group, Inc.
4.98%
Royce Investment Partners
4.27%
Other
68.79%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
27.45%
Investment Advisor/Hedge Fund
20.20%
Individual Investor
15.64%
Hedge Fund
9.85%
Research Firm
5.12%
Bank and Trust
0.09%
Insurance Company
0.04%
Pension Fund
0.03%
Other
21.57%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
260
14.87M
80.40%
-7.61M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
2023Q1
407
14.85M
86.69%
-4.67M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Whetstone Capital Advisors, LLC
1.51M
8.16%
--
--
Apr 18, 2025
Weintraub (Michael)
1.38M
7.49%
--
--
Apr 29, 2025
BlackRock Institutional Trust Company, N.A.
1.17M
6.31%
+5.50K
+0.47%
Mar 31, 2025
The Vanguard Group, Inc.
921.85K
4.98%
-13.71K
-1.47%
Mar 31, 2025
Royce Investment Partners
994.30K
5.38%
-75.26K
-7.04%
Mar 31, 2025
William Blair & Company, L.L.C. (Research)
631.03K
3.41%
+29.65K
+4.93%
Mar 31, 2025
Rice Hall James & Associates, LLC
576.17K
3.12%
-1.57K
-0.27%
Mar 31, 2025
Febbo (William J)
530.85K
2.87%
-83.11K
-13.54%
Apr 29, 2025
Kennedy Capital Management LLC
478.40K
2.59%
-115.60K
-19.46%
Mar 31, 2025
Parkman Healthcare Partners LLC
475.00K
2.57%
+475.00K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Janus Henderson Small Cap Growth Alpha ETF
0.38%
iShares Micro-Cap ETF
0.05%
iShares Russell 2000 Growth ETF
0.02%
Avantis US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Ver más
Janus Henderson Small Cap Growth Alpha ETF
Proporción0.38%
iShares Micro-Cap ETF
Proporción0.05%
iShares Russell 2000 Growth ETF
Proporción0.02%
Avantis US Small Cap Equity ETF
Proporción0.02%
ProShares Hedge Replication ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI